Jegere Sanda, Narbute Inga, Erglis Andrejs
Sanda Jegere, Inga Narbute, Andrejs Erglis, Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Riga, LV1002, Latvia.
World J Cardiol. 2014 Jun 26;6(6):393-404. doi: 10.4330/wjc.v6.i6.393.
For many years, coronary angiography has been considered "the gold standard" for evaluating patients with coronary artery disease. However, angiography only provides a planar two-dimensional silhouette of the lumen and is unsuitable for the precise assessment of atherosclerosis. With the introduction of intravascular imaging, direct visualization of the arterial wall is now feasible. Intravascular imaging modalities extend diagnostic information, thereby enabling more precise evaluation of plaque burden and vessel remodeling. Of all technologies, intravascular ultrasound (IVUS) is the most mature and widely used intravascular imaging technique. Optical coherence tomography (OCT) is an evolving technology that has the highest spatial resolution of existing imaging methods, and it is becoming increasingly widespread. These methods are useful tools for planning interventional strategies and optimizing stent deployment, particularly when stenting complex lesions. We strongly support the mandatory use of IVUS for left main percutaneous coronary intervention (PCI). In addition, it can be used to evaluate vascular responses, including neointimal growth and strut apposition, during follow-ups. Adequately powered randomized trials are needed to support IVUS or OCT use in routine clinical practice and to answer whether OCT is superior to IVUS in reducing adverse events when used to guide PCI. The current perception and adoption of innovative interventional devices, such as bioabsorbable scaffolds, will increase the need for intravascular imaging in the future.
多年来,冠状动脉造影一直被视为评估冠心病患者的“金标准”。然而,血管造影仅提供管腔的平面二维轮廓,不适用于动脉粥样硬化的精确评估。随着血管内成像技术的引入,现在可以直接观察动脉壁。血管内成像方式扩展了诊断信息,从而能够更精确地评估斑块负荷和血管重塑。在所有技术中,血管内超声(IVUS)是最成熟且应用最广泛的血管内成像技术。光学相干断层扫描(OCT)是一种不断发展的技术,具有现有成像方法中最高的空间分辨率,并且越来越普及。这些方法是规划介入策略和优化支架置入的有用工具,尤其是在处理复杂病变进行支架置入时。我们强烈支持在左主干经皮冠状动脉介入治疗(PCI)中强制使用IVUS。此外,它可用于评估随访期间的血管反应,包括新生内膜生长和支架贴壁情况。需要开展足够样本量的随机试验来支持IVUS或OCT在常规临床实践中的应用,并回答在用于指导PCI时OCT是否在减少不良事件方面优于IVUS。当前对生物可吸收支架等创新性介入装置的认知和应用,将增加未来对血管内成像的需求。